Hexameric porphobilinogen synthase as a target for the development of antibiotics and herbicides

Details for Australian Patent Application No. 2004257208 (hide)

Owner Fox Chase Cancer Center

Inventors Jaffe, Eileen K.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004257208

PCT Pub. Number WO2005/007817

Priority 60/485,253 07.07.03 US; 60/577,312 04.06.04 US

Filing date 7 July 2004

Wipo publication date 27 January 2005

Acceptance publication date 25 February 2010

International Classifications

A61K 31/00 (2006.01)

Event Publications

16 February 2006 PCT application entered the National Phase

  PCT publication WO2005/007817 Priority application(s): WO2005/007817

25 February 2010 Application Accepted

  Published as AU-B-2004257208

24 June 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004257209-Exo-specific amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof

2004257206-Recombinant expression of Streptococcus pyogenes cysteine protease and immunogenic compositions thereof